Peptides — a diverse class of short amino acid chains — are increasingly in the spotlight, not just in scientific research but also in public discourse. From regulatory scrutiny by the U.S. Food and Drug Administration (FDA) to surging consumer interest, the landscape around peptides in 2025–2026 reflects a sector at the intersection of science, wellness, and market demand. Public Interest & Market Demand Peptides have transcended niche laboratory discussions to become widely